NEW YORK (GenomeWeb News) – A federal court judge has granted Illumina's motion for summary judgment that its sequencing technology does not infringe three Life Technologies patents.

In the decision handed down on Wednesday, Judge Cathy Ann Bencivengo of the US District Court for the Southern District of California said that Illumina does not infringe US Patent Nos. 5,616,478; 5,958,698; and 6,001,568 held by Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.